If you have persistent or longstanding persistent afib and are considering a catheter ablation, you may qualify to participate in the aMAZE Study. This study is for the purpose of determining if adding the LARIAT procedure before a catheter ablation can help. Learn more about the study at: The aMAZE Study will evaluate the benefits …
Read More
The VICTORY AF (Evaluation of Multielectrode Phased RF Technology in Persistent AF) Trial, sponsored by Medtronic, is studying patients undergoing a catheter ablation with Medtronic's Phased Radiofrequency (RF) system. To learn more, see: VICTORY AF Trial Studies Phased Radiofrequency (RF) System for Persistent and Longstanding Persistent Atrial Fibrillation
Read More
The Food and Drug Administration (FDA) approved the AtriCure Synergy Ablation System for the treatment of persistent and longstanding persistent atrial fibrillation in patients undergoing another heart surgery. The Synergy bipolar radiofrequency clamp is the only surgical ablation device with FDA approval for afib treatment. Learn more: FDA Advisory Panel Recommends, and FDA Approves, Bipolar …
Read More
An FDA advisory panel voted that the overall benefits outweighed the risks in afib ablations using the AtriCure Synergy bipolar radiofrequency clamp. This was based on the results of the ABLATE clinical trial for ablation of persistent or longstanding persistent atrial fibrillation during other heart surgery. The panel recommended that the FDA approve it, setting …
Read More
Hybrid ablation is an emerging treatment for patients with persistent and longstanding persistent atrial fibrillation. It is a dual approach, in which an electrophysiologist ablates from inside the heart and the cardiac surgeon ablates on the outside the heart. Dr. James Edgerton, a cardiac surgeon at The Heart Hospital Baylor Plano in Texas, who spoke …
Read More
Today's featured story comes from Boston Atrial Fibrillation Symposium where we talked with Dr. Pierre Jais about new 5-year catheter ablation results that his team at Bordeaux has just published. One-third of these patients had persistent or longstanding persistent atrial fibrillation. These results have been described in the media as "sobering", but hear Dr. Jais …
Read More
Catheter ablation in persistent and longstanding persistent atrial fibrillation patients has traditionally had low success rates since many of the triggers causing atrial fibrillation are dispersed throughout the left atrium. Thus isolation of the pulmonary veins, which works well for those with paroxysmal atrial fibrillation, is often an incomplete solution for those with persistent forms …
Read More